Analysis and Studies - Products analysis
Pharmaceutical products: import and export
October 6th 2023
Pharmaceutical products, often simply referred to as pharmaceuticals or medicines, are a diverse category of substances and compounds primarily developed for the purpose of preventing, treating, diagnosing, or alleviating medical conditions and diseases in humans and, in some cases, animals. These products play a crucial role in modern healthcare and are instrumental in improving the quality of life and extending the lifespan of individuals worldwide.
Pharmaceutical products encompass a wide range of substances, including synthetic drugs, biologics, vaccines, antibiotics, antivirals, antifungals, pain relievers, vitamins, and many more. They are designed to address various health issues, from common ailments to complex and life-threatening diseases.
In the year 2021, the global trade in pharmaceutical products emerged as a significant economic force, ranking as the sixth most traded commodity with a staggering total trade value of $806 billion. This impressive figure reflects a notable growth rate of 20.8% when compared to the previous year, with exports of pharmaceutical products surging from $668 billion in 2020 to reach the remarkable $806 billion mark in 2021. This sector's substantial contribution to the global economy is further underscored by the fact that pharmaceutical products constituted 3.83% of the entire world's trade.
Diving into the specifics of this burgeoning industry, it's worth highlighting the top exporting nations in 2021. Germany led the pack, exporting pharmaceutical products valued at $115 billion, followed closely by Switzerland with $90.2 billion in exports. The United States, a key player in the global pharmaceutical landscape, secured the third position with exports totaling $81.6 billion, while Belgium and Ireland also made significant contributions, exporting pharmaceutical products valued at $71.1 billion and $70.6 billion, respectively.
On the import side of this thriving industry, the United States led the way in 2021, importing pharmaceutical products worth a staggering $145 billion. Germany was the second-largest importer, with imports totaling $76.6 billion, followed by Belgium at $44 billion, Switzerland at $40.2 billion, and France at $34.9 billion.
SkyMinder: Know Your Business Partner
SkyMinder is the business information platform powered by CRIF, giving access to in-depth credit and financial data on companies all over the world. Thanks to our international presence and long-standing experience with local information providers, every country is available on SkyMinder, without data accessibility limits or updating issues. If you are evaluating the possibility of doing business with a company in this industry, SkyMinder can help you assess your potential partner.
Discover more about our solutions and don't hesitate to contact us!